Benzinga··NaKailera Raises $718.8M in IPO as Obesity Care Biotech Enters Public Markets
Kailera Therapeutics raises $718.8M in IPO at $16/share as obesity care biotech enters public markets with strong underwriter demand.
KLRAIPOcapital raising
underwriters
6 articlesBenzinga··Na
GlobeNewswire Inc.··NaYork Water Taps Capital Markets With Stock Offering to Fund Growth Strategy
York Water Company announced a proposed public stock offering on April 15, 2026, with proceeds earmarked for capital investment, debt reduction, and potential acquisitions.
YORWacquisitionsdebt repayment
Benzinga··Suja Life, Inc.Cold-Pressed Juice Maker Suja Life Files for Nasdaq IPO with Goldman Sachs Leading
Suja Life files for Nasdaq IPO under ticker $SUJA with Goldman Sachs, Jefferies, and William Blair leading. Offering size and price range pending.
GSGSpAGSpCGSpDJEFIPONasdaq listing
GlobeNewswire Inc.··Celldex Therapeutics, Inc.Celldex Raises $345M in Public Offering as Underwriters Exercise Full Option
Celldex Therapeutics closed $345M public offering at $29/share with full underwriter option exercise, netting approximately $401M in total gross proceeds.
CLDXpublic offeringcommon stock
Benzinga··Not SpecifiedHMH Holding Completes $193.8M IPO, Begins Nasdaq Trading
HMH Holding completed $193.8M IPO, raising capital through 10.52M share offering at $20/share, now trading on Nasdaq.
HMHIPOoil and gas
GlobeNewswire Inc.··Medline Inc.Medline Completes $3.99B Secondary Offering as PE Sponsors Cash In
Medline Inc. completed a $3.99 billion secondary stock offering as major PE sponsors including Blackstone and Carlyle Group partially exit their holdings in the medical supply giant.
BXMDLNCGsecondary offeringshare offering